Pooled Amplicon Deep Sequencing of Candidate Plasmodium falciparum Transmission-Blocking Vaccine Antigens.
暂无分享,去创建一个
S. Meshnick | F. Martinson | I. Hoffman | N. Brazeau | B. Ngasala | A. Mårtensson | J. Juliano | M. Randrianarivelojosia | D. Saunders | Nirbhay Kumar | A. Tshefu | Christian M. Parobek | B. Das | R. Dhar | C. Lon | K. Mwandagalirwa
[1] Yuming Guo,et al. The effect of air pollution on human physiological function in China: a longitudinal study , 2015, The Lancet.
[2] J. Bailey,et al. Using Amplicon Deep Sequencing to Detect Genetic Signatures of Plasmodium vivax Relapse. , 2015, The Journal of infectious diseases.
[3] Peter G. Kremsner,et al. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. , 2015 .
[4] Steve M. Taylor,et al. Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study. , 2015, The Journal of infectious diseases.
[5] Badria B. El-Sayed,et al. Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors that Affect Treatment Outcomes for P. falciparum Malaria after Artemether-Lumefantrine and Artesunate-Amodiaquine , 2014, The American journal of tropical medicine and hygiene.
[6] A. Barry,et al. Strategies for Designing and Monitoring Malaria Vaccines Targeting Diverse Antigens , 2014, Front. Immunol..
[7] A. Sabbagh,et al. Genetic diversity of VAR2CSA ID1-DBL2Xb in worldwide Plasmodium falciparum populations: impact on vaccine design for placental malaria. , 2014, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[8] Nash R. Aragam,et al. Pooled deep sequencing of Plasmodium falciparum isolates: an efficient and scalable tool to quantify prevailing malaria drug-resistance genotypes. , 2013, The Journal of infectious diseases.
[9] J. Bailey,et al. Use of massively parallel pyrosequencing to evaluate the diversity of and selection on Plasmodium falciparum csp T-cell epitopes in Lilongwe, Malawi. , 2012, The Journal of infectious diseases.
[10] Z. Premji,et al. Plasmodium falciparum population dynamics during the early phase of anti-malarial drug treatment in Tanzanian children with acute uncomplicated malaria , 2011, Malaria Journal.
[11] T. Bousema,et al. The Dynamics of Naturally Acquired Immune Responses to Plasmodium falciparum Sexual Stage Antigens Pfs230 & Pfs48/45 in a Low Endemic Area in Tanzania , 2010, PloS one.
[12] M. P. Cummings,et al. Extreme Polymorphism in a Vaccine Antigen and Risk of Clinical Malaria: Implications for Vaccine Development , 2009, Science Translational Medicine.
[13] S. Meshnick,et al. Nonradioactive heteroduplex tracking assay for the detection of minority-variant chloroquine-resistant Plasmodium falciparum in Madagascar , 2009, Malaria Journal.
[14] V. A. Stewart,et al. Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial , 2008, PloS one.
[15] H. Stunnenberg,et al. Epitope Analysis of the Malaria Surface Antigen Pfs48/45 Identifies a Subdomain That Elicits Transmission Blocking Antibodies* , 2007, Journal of Biological Chemistry.
[16] J. Kihonda,et al. A longitudinal study of immune responses to Plasmodium falciparum sexual stage antigens in Tanzanian adults , 2007, Parasite immunology.
[17] R. Carter. Transmission blocking malaria vaccines. , 2001, Vaccine.
[18] K. Mendis,et al. Malaria transmission-blocking vaccines—how can their development be supported? , 2000, Nature Medicine.
[19] Babita Sharma,et al. Structure and Mechanism of a Transmission Blocking Vaccine Candidate Protein Pfs25 from P. falciparum: A Molecular Modeling and Docking Study , 2008, Silico Biol..